Immunology 1995: Vol 86 Index

9 Pages·1995·2.4 MB·English

Author Index
AGARWAL S. see KESTLER D.P. BODMER M.W. see MORGAN A.
AGEA E. see SPINOZZI F. BOERSMA W.J.A. see HOEFAKKER S.
AHERN M. see BECKMAN I. BONATO V.L.D. see SILVA C.L.
AHLSTEDT S. see DAHLMAN-HOGLUND A. BORREBAECK C.A.K. see MARTENSSON C.
AKIMOTO Y. see IMAI Y. BOUCHER W. see CONTI P.
ALZANI R. see ZINETTI M. BRAND D.D. see MIYAHARA H.
AMIRAYAN N., FURRIE E., DELEUIL F., MELLOR A., BRONDZ B.D., KAZANSKY D.B., CHERNYSHOVA A.D. &
LESERMAN L. & MACHY P. Influence of MHC class I IVANOV V.S. Peptides of a major histocompatibility complex
molecules on T-cell proliferation induced by CD3 or Thy-1 class I (K°) molecule cause prolongation of skin graft survival
stimulation, 71 and induce specific down-regulatory T cells demonstrable in the
AN S. see ZENG L. mixed lymphocyte reaction, 219
ANDERSSON J. see SANDER B. BRUNEAU G. see CONTI P.
ANDERSSON U. see SANDER B. BRYAN-POOLE N. see ZUCKERMAN S.H.
ANDONEGUIG., TREVANI A.S., DRAN G. & GEFFNER J.R.
Effect of nitric oxide donors on neutrophil responses induced by CALDER V.L. see GREENWOOD J.
immune complexes, 646 CARLSSON R. see MARTENSSON C.
ARAMAKI Y. see MURAI M. CASTANOS-VELEZ E., BIBERFELD P. & PATARROYO M.
ARANGUEZ I. see TORRES C. Extracellular matrix proteins and integrin receptors in reactive
AWINO E. see BEMBRIDGE G.P. and non-reactive lymph nodes, 270
AZUMA T. see KANEKO Y. CATTANEO A. see MOZZANICA N.
CAULFIELD M.J. & STANKO D. T-cell dependent response to
BABIUK L.A. see BACA-ESTRADA M.E. immune complexes abrogates B-cell unresponsiveness to
BACA-ESTRADA M.E., LIANG X., BABIUK L.A. & YOO D. pneumococcal cell wall polysaccharide, 331
Induction of mucosal immunity in cotton rats to haemagglutinin— CHADEE K. see SEGUIN R.
esterase glycoprotein of bovine coronavirus by recombinant CHALLACOMBE S.J. see SWEET S.P.
adenovirus, 134 CHAN W.C. see ROBINSON K.
BACH J.-F. see PATRY C. CHAPLIN L. see MORGAN A.
BACON M. see BINNS R.M. CHEN M. see MULLER D.
BALDWIN C.L. see OKRAGLY A.J. see also TALMOR M.
BALK H.P. see HOEFAKKER S. CHEN X.-J., WIEDERMANN U., DAHLGREN U., HANSON
BALOGH P. & KUMANOVICS A. Tissue-associated phenotypic L.A & ENERBACK L. T-cell-independent and T-cell-dependent
heterogeneity of peripheral B cells in mice, 560 IgE responses to the nematode Nippostrongylus brasiliensis:
BAMBERG T. see MCGEE D.W. comparison of serum IgE and mast-cell-bound IgE, 351
BARANYI L. see KANEKO Y. CHERNYSHOVA A.D. see BRONDZ B.D.
BARBACANE R.C. see CONTI P. CHIN B. see BISSONNETTE E.Y.
BASKETTER D.A. see DEARMAN R.J. CIPOLLARO DE L’ERO G. see GALDIERO M.
BECKMAN I., SHEPHERD D., FIRGAIRA F. & AHERN M. CLAASSEN E. see HOEFAKKER S.
Age-related defects in CD2 receptor-induced activation in human CLERICI M. see MOZZANICA N.
T-cell subsets, 533 CODNER M.A. see TALMOR M.
BEESON D.M.W. see MULCAHY A..F. COE J.E., SCHELL R.F. & ROSS M.J. Immune response in the
BEFUS A.D. see BISSONNETTE E.Y. hamster: definition of a novel IgG not expressed in all hamster
BELIA S. see SPINOZZI F. strains, 141
BELLABY T. see ROBINSON K. COLEMAN J.W. see TAYLOR A.M.
BEMBRIDGE G.P., MACHUGH N.D., MCKEEVER D., AWINO see also WILLIAMS C.M.M.
E., SOPP P., COLLINS R.A., GELDER K.I. & HOWARD C.J. COLLINS R.A. see BEMBRIDGE G.P.
CD45RO expression on bovine T cells: relation to biological COLOVAI A.I. see HARRIS P.E.
function, 537 COLSTON M.J. see MISRA N.
BERTOTTO A. see SPINOZZI F. CONTI P., BOUCHER W., LETOURNEAU R., FELICIANI C.,
BHEEKHA ESCURA R., WASSERBAUER E., REALE M., BARBACANE R.C., VLAGOPOULOS P.,
HAMMERSCHMID F., PEARCE A., KIDD P. & MUDDE BRUNEAU G., THIBAULT J. & THEOHARIDES T.C.
G.C. Regulation and targeting of T-cell immune responses by IgE Monocyte chemotactic protein-1 provokes mast cell aggregation
and IgG antibodies, 343 and [PH]5HT release, 434
BIANCHI A.T.J. see KIMMAN T.G. COZZI E. see ZINETTI M.
BIANCO N.E. see DE SANCTIS J.B. CUMBERBATCH M. see HOPE J.C.
BIBERFELD P. see CASTANOS-VELEZ E. CUNNINGHAM A.C. & KIRBY J.A. Regulation and function of
BILYK N. & HOLT P.G. Cytokine modulation of the adhesion molecule expression by human alveolar epithelial cells, 279
immunosuppressive phenotype of pulmonary alveolar CUNNINGHAM A.C. see WILSON J.L.
macrophage populations, 231
BINNS R.M., LICENCE S.T., WHYTE A., WILBY M., DA SILVA M.F. see SILVA C.L.
ROTHKOTTER H.-J. & BACON M. Genetically determined DAHLGREN U. see CHEN X.-J.
CD45 variant of value in leucocyte tracing in vivo in the pig, 25 see also DAHLMAN-HOGLUND A.
BISSONNETTE E.Y., CHIN B. & BEFUS A.D. Interferons DAHLMAN-HOGLUND A., DAHLGREN U., AHLSTEDT S.,
differentially regulate histamine and TNF-« in rat intestinal HANSON L.A & TELEMO E. Bystander suppression of the
mucosal mast cells, 12 immune response to human serum albumin in rats fed ovalbumin,
BLANCA I. see DE SANCTIS J.B. 128
670 Author Index
DAI R. & STREILEIN J.W. Sensitizing capacity of Langerhans’ GUENTHNER &.T. see MAVES K.K.
cells obtained from ultraviolet-B-exposed murine skin, 661 GUILLET J.-G. see PLASMAN N.
DAMM O. see SANDER B.
DAUBENER W., MACKENZIE C. & HADDING U. HADDING U. see DAUBENER W.
Establishment of T-helper type 1- and T-helper type 2-like human HAKANSSON L. see SANDER B.
Toxoplasma antigen-specific T-cell clones, 79 HALL R.E. see KESTLER D.P.
DAVIES M.E. see HORNER A. HALLSTROM O. see KERTTULA T.O.
DAY N.K. see KIZAKI T. HAMMERSCHMID F. see BHEEKHA ESCURA R.
DE BRUIN T.M.G. see KIMMAN T.G. HANBY-FLARIDA M. see OKRAGLY A.J.
DE SANCTIS J.B., BLANCA I. & BIANCO N.E. Expression of HANSON L.A sée CHEN X.-J.
different lipoprotein receptors in natural killer cells and their see also DAHLMAN-HOGLUND A.
effect on natural killer proliferative and cytoxic activity, 399 HARPER A.D. see TALMOR M.
DEARMAN R.J. see HOPE J.C. HARRIS C.L. & MORGAN B.P. Characterization of a glycosyl-
DEARMAN R.J., BASKETTER D.A. & KIMBER I. Differential phosphatidylinositol anchor-deficient subline of Raji cells. An
cytokine production following chronic exposure of mice to analysis of the functional importance of complement inhibitors on
chemical respiratory and contact allergens, 545 the Raji cell line, 311
DELEUIL F. see AMIRAYAN N. HARRIS D.P. see ROMAN E.
DEMAISON C., RAVIRAJAN C.T., ISENBERG D.A. & ZOUALI HARRIS P.E., COLOVAI A.I., MAFFEI A., LIU Z. & SUCIU
M. Analysis of variable region genes encoding anti-Sm and anti- FOCA N. Major histocompatibility complex class I presentation
cardiolipin antibodies from a systemic lupus erythematosus of exogenous and endogenous protein-derived peptides by a
patient, 487 transfected human monocyte cell line, 606
DEMITRI M.T. see ZINETTI M. HEEG K. see MARTINEZ-KINADER B.
DENSEN P. see MAVES K.K. HERBELIN A. see PATRY C.
DIAMOND A.G. see MULCAHY A.F. HERNANDEZ-PANDO R., OROZCO H. & MANCILLA R. T-cell
DIAZ-MITOMA F. see KRYWORUCKHO M. lung granulomas induced by sepharose-coupled Mycobacterium
DONNARUMMA G. see GALDIERO M. tuberculosis protein antigens: immunosuppressive phenomena
DRAN G. see ANDONEGUI G. reversed with cyclophosphamide and indomethacin, 506
DYBWAD A. see OSTENSTAD B. HILDEMAN D. see MULLER D.
HIRANO H. see IMAI Y.
EMOTO M. see KITA E. HIROKAWA M., KITABAYASHI A., KUROKI J. & MIURA
EMTAGE J.S. see MORGAN A. A.B. Signal transduction by B7/BB1 expressed on activated T
ENERBACK L. see CHEN X.-J. lymphocytes: cross-linking of B7/BB1 induces protein tyrosine
ERIKSSON H. & SJOGREN H.O. Inhibition of activation of phosphorylation and synergizes with signalling through T-cell
human T lymphocytes by the complement C1 esterase inhibitor, receptor/CD3, 155
304 HIROMATSU K. see USAMI J.
EVANS G.F. see ZUCKERMAN S.H. HOEFAKKER §S., BALK H.P., BOERSMA W.J.A., VAN JOOST
TH., NOTTEN W.R.F. & CLAASSEN E. Migration of human
FANTUZZI G. see ZINETTI M. antigen-presenting cells in a human skin graft onto nude mice
FELICIANI C. see CONTI P. model after contact sensitization, 296
FERRARIO E. see MOZZANICA N. HOFFMAN L.A. see TALMOR M.
FIELDING I. see HOPE J.C. HOGARTH P.M. see GAVIN A.L.
FINZI A.F. see MOZZANICA N. HOLT P.G. see BILYK N.
FIRGAIRA F. see BECKMAN I. HOLTER W. see SCHWARZ M.
FORRE @. see OSTENSTAD B. HOPE J.C., CUMBERBATCH M., FIELDING I., DEARMAN
FRANZ B. see HORNER A. R.J., KIMBER I. & HOPKINS S.J. Identification of dendritic
FRATELLI M. see ZINETTI M. cells as a major source of interleukin-6 in draining lymph nodes
FURRIE E. see AMIRAYAN N. following skin sensitization of mice, 441
FURRIE E., TURNER M.W. & STROBEL S. Partial HOPKINS S.J. see HOPE J.C.
characterization of a circulating tolerogenic moiety which, after a HORNER A., DAVIES M.E. & FRANZ B. Chrondocyte—
feed of ovalbumin, suppresses delayed-type hypersensitivity in peripheral blood mononuclear cell interactions: the role of
recipient mice, 480 ICAM-1, 584
HOWARD C.J. see BEMBRIDGE G.P.
GALDIERO F. see GALDIERO M. HOWIE D. see SANDILANDS G.P.
GALDIERO M., CIPOLLARO DE L’ERO G., DONNARUMMA HULETT M.D. see GAVIN A.L.
G., MARCATILI A. & GALDIERO F. Interleukin-1 and HUNT J.S. see ROBY K.F.
interleukin-6 gene expression in human monocytes stimulated
with Salmonella tymphimurium porins, 612 IFVERSEN P. see MARTENSSON C.
GALLI G. see ZINETTI M. IMAI Y., AKIMOTO Y., MIZUOCHI S., KIMURA T., HIRANO
GALLI S.J. see TAYLOR A.M. H. & IRIMURA T. Restricted expression of galactose/N-
GAVIN A.L., SNIDER J., HULETT M.D., MCKENZIE L.F.C. & acetylgalactosamine-specific macrophage C-type lectin to
HOGARTH P.M. Expression of recombinant soluble FceRI: connective tissue and to metastatic lesions in mouse lung, 591
function and tissue distribution studies, 392 INAGAKI H. see USAMI J.
GEFFNER J.R. see ANDONEGUI G. IRIMURA T. see IMAI Y.
GELDER K.I. see BEMBRIDGE G.P. ISENBERG D.A. see DEMAISON C.
GERSHON D. see ROBY K.F. IVANOV V5S. see BRONDZ B.D.
GHEZZI P. see ZINETTI M. IVANYI J. see ROMAN E.
GLASEBROOK A.L. see ZUCKERMAN S.H.
GOETZL E.J. see ZENG L. JANUARIO A. see SILVA C.L.
GOLDBERG I. see OREN R. JONES J. & MORGAN B.P. Apoptosis is associated with reduced
GOOD R.A. see KIZAKI T. expression of complement regulatory molecules, adhesion
GREENWOOD J., WANG Y. & CALDER V.L. Lymphocyte molecules and other receptors on polymorphonuclear leucocytes:
adhesion and transendothelial migration in the central nervous functional relevance and role in inflammation, 651
system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1, 408 JONES N.D. see MORGAN A.
GRIGNANI F. see SPINOZZI F. JURCEVIC S. see ROMAN E.
Author Index 671
KANAMORI H., KODAMA T. & YAZAKI Y. The 5’ coding expression and increases the susceptibility of uveal melanoma cells
sequence of IL-2 receptor « chain mRNA mediates mRNA to natural killer cell-mediated cytolysis, 263
stabilization by HTLV-1 Rex, 551 MACDONALD T.T. see PENNEY L.
KANEKO Y., OKADA N., BARANYI L., AZUMA T. & OKADA MACHUGH N.D. see BEMBRIDGE G.P.
H. Antagonistic peptides against human anaphylatoxin CSa, 149 MACHY P. see AMIRAYAN N.
KANG A.H. see MIYAHARA H. MACKENZIE C. see DAUBENER W.
KAPP J.A. see ZIMECKI M. MACSWEEN R.N.M. see SANDILANDS G.P.
KASHIBA S. see KITA E. MAEDA K. see USAMI J.
KAZANSKY D.B. see BRONDZ B.D. MAEDA T. see MURAKAMI Y.
KELLER K. see SEGUIN R. | : MAFFEI A. see HARRIS P.E.
KERTTULA T.O., HALLSTROM O. & MAKI M. Phenotypical MAJDIC O. see SCHWARZ M.
characterization of peripheral blood T cells in patients with coeliac MAKI M. see KERTTULA T.O.
disease: elevation of antigen-primed CD45RO* T lymphocytes, 104 MANCILLA R. see HERNANDEZ-PANDO R.
KESTLER D.P., AGARWAL S. & HALL R.E. Up-regulation of MARCATILI A. see GALDIERO M.
cytokine mRNA in human monocytes and myeloid cell lines by MARTENSSON C., IFVERSEN P., BORREBAECK C.A.K. &
the differentiation/activation factor p48, 463 CARLSSON R. Enhancement of specific immunoglobulin
KIDD P. see BHEEKHA ESCURA R. production in SCID-hu-PBL mice after in vitro priming of human
KILSHAW P.J. see PENNEY L. B cells with superantigen, 224
KIMBER I. see DEARMAN R.J. MARTIN S.J. see VYAKARNAM A.
see also HOPE J.C. MARTINEZ-KINADER B., LIPFORD G.B., WAGNER H. &
KIMMAN T.G., DE BRUIN T.M.G., VOERMANS J.J.M., HEEG K. Sensitization of MHC class I-restricted T cells to
PEETERS B.P.H. & BIANCHI A.T.J. Development and antigen exogenous proteins: evidence for an alternative class I-restricted
specificity of the lymphoproliferation response of pigs to antigen presentation pathway, 287
pseudorabies virus: dichotomy between secondary B- and T-cell MATEAR P.M. see VYAKARNAM A.
responses, 372 MATSUMOTO Y. see USAMI J.
KIMURA T. see IMAI Y. MATSUZAKI G. see SONODA K.
KIRBY J.A. see CUNNINGHAM A.C. MAVES K.K., GUENTHNER S.T., DENSEN P., MOSER D.R. &
KIRBY J.A. see WILSON J.L. WEILER J.M. Cloning and characterization of the cDNA
KITA E., EMOTO M., NISHIKAWA F., YOSHIKAI Y. & encoding guinea-pig properdin: a comparison of properdin from
KASHIBA S. Conversion of Salmonella typhimurium to L-forms three species, 475
contributes to the maintenance of acquired immunity against MAZURIER J. see ZIMECKI M.
murine typhoid, 206 MCGEE D.W., BAMBERG T., VITKUS S.J.D. & MCGHEE J.R.
KITABAYASHI A. see HIROKAWA M. A synergistic relationship between TNF-a, IL-18 and TGF-f1 on
KIZAKI T., YAMASHITA H., OH-ISHI S., DAY N.K., GOOD IL-6 secretion by the IEC-6 intestinal epithelial cell line, 6
R.A. & OHNO H. Immunomodulation by cells of mononuclear MCGHEE J.R. see MCGEE D.W.
phagocyte lineage in acute cold-stressed or cold-acclimatized mice, MCKEEVER D. see BEMBRIDGE G.P.
456 MCKENZIE L.F.C. see GAVIN A.L.
KNAPP W. see SCHWARZ M. MCLAREN A.P. see SANDILANDS G.P.
KODAMA T. see KANAMORI H. MEGYERI P., PABST K.M. & PABST M.J. Serine protease
KOIDE Y., YOSHIDA A., UCHIJIMA M. & YOSHIDA T.O. inhibitors block priming of monocytes for enhanced release of
Unimpaired clearance of Mycobacterium bovis BCG infection in superoxide, 629
selectively T-cell anergic TCR-V£8.2 transgenic mice, 499 MELLOR A. see AMIRAYAN N.
KONG Y.-Y. see MURAKAMI Y. MIGLIORATI G. see SPINOZZI F.
KONING F. see ORSINI D.L.M. MINTO M. see ZINETTI M.
KOOY Y.M.C. see ORSINI D.L.M. MISRA N., MURTAZA A., WALKER B., NARAYAN N.P.S.,
KOPOLOVIC J. see OREN R. MISRA R.S., RAMESH V., SINGH S., COLSTON M.J. &
KRYWORUCKHO M., DIAZ-MITOMA F. & KUMAR A. CD44 NATH I. Cytokine profile of circulating T cells of leprosy
isoforms containing exons V6 and V7 are differentially expressed patients reflects both indiscriminate and polarized T-helper
on mitogenically stimulated normal and Epstein-Barr virus- subsets: T-helper phenotype is stabie and uninfluenced by related
transformed human B cells, 41 antigens of Mycobacteria leprae, 97
KUMANOVICS A. see BALOGH P. MISRA RS. see MISRA N.
KUMAR A. see KRYWORUCKHO M. MIURA A.B. see HIROKAWA M.
KUROKI J. see HIROKAWA M. MIYAHARA H., MYERS L.K., ROSLONIEC E.F., BRAND
D.D., SEYER J.M., STUART J.M. & KANG A.H.
LAMB J.R. see O'BRIEN R.M. Identification and characterization of a major tolerogenic T-cell
LANGERMANS J.A.M. see SAMSOM J.N. epitope of type II collagen that suppresses arthritis in B10.RIII
LAUFER J. see OREN R. mice, 110
LEA T. see OSTENSTAD B. MIZUOCHI S. see IMAI Y.
LEHUEN A. see PATRY C. MONTEIRO R.C. see PATRY C.
LESERMAN L. see AMIRAYAN N. MORACA R. see SPINOZZI F.
LETOURNEAU R. see CONTI P. MORENO C. see ROMAN E.
LIANG X. see BACA-ESTRADA M.E. MORGAN A., JONES N.D., NESBITT A.M., CHAPLIN L.,
LICENCE S.T. see BINNS R.M. BODMER M.W. & EMTAGE JS. The N-terminal end of the
LIMA V.M.F. see SILVA C.L. Cy2 domain of chimeric human IgG1 anti- HLA-DR is necessary
LIPFORD G.B. see MARTINEZ-KINADER B. for Clq, FeyRI and FeyRII binding, 319
LIU Z. see HARRIS P.E. MORGAN B.P. see HARRIS C.L.
LOWRIE D.B. see SILVA C.L. see also JONES J.
LU P. & SHAROM F.J. Gangliosides are potent immunosuppressors MOSER D.R. see MAVES K.K.
of IL-2-mediated T-cell proliferation in a low protein MOZZANICA N., CATTANEO A., TRABATTONI D., FINZI
environment, 356 A.F., SCHMITT E., FERRARIO E., CLERICI M., VIGNATI
LYCKE N. see VAJDY M. G. & VILLA M.L. Production of type-1 and type-2 cytokines by
peripheral blood mononuclear cells of psoriatic patients, 422
MA D. & NIEDERKORN J.Y. Transforming growth factor-B MUDDE G.C. see BHEEKHA ESCURA R.
down-regulates major histocompatibility complex class I antigen MUKASA A. see SONODA K.
672 Author Index
MULCAHY A.F., BEESON D.M.W., WILLCOX N. & variation in the proliferative rate and lifespan of «8 TCR* and 6
DIAMOND A.G. Presentation of endogenous acetylcholine TCR? intraepithelial lymphocytes in the murine small intestine,
receptor antigen to a specific CD4* T-cell line by a transfected 212
B-cell line, 116 PIETERS R.H.H. see SCHIELEN P.
MULLER D., CHEN M., VIKINGSSON A., HILDEMAN D. & PIETRO R.L.R. see SILVA C.L.
PEDERSON K. Oestrogen influences CD4* T-lymphocyte PLASMAN N., GUILLET J.-G. & VRAY B. Impaired protein
activity in vivo and in vitro in B2-microglobulin-deficient mice, 162 catabolism in Trypanosoma cruzi-infected macrophages: possible
MURAI M., ARAMAKI Y. & TSUCHIYA S. Identification of the involvement in antigen presentation, 636
serum factor required for liposome-primed activation of mouse
peritoneal macrophages. Modified «2-macroglobulin enhances Fey RAHMAN D. see SWEET S.P.
receptor-mediated phagocytosis of opsonized sheep red blood RAMESH V. see MISRA N.
cells, 64 RAVIRAJAN C.T. see DEMAISON C.
MURAI M., ARAMAKI Y. & TSUCHIYA S. Modification of «- REALE M. see CONTI P.
macroglobulin into a macrophage-activating factor through the RICCARDI C. see SPINOZZI F.
action of liposome-stimulated B-cell membranous glycosidases, 58 ROBINSON K., BELLABY T., CHAN W.C. & WAKELIN D.
MURAKAMI Y., KONG Y.-Y., NISHIMURA Y., NOMOTO K.., High levels of protection induced by a 40-mer synthetic peptide
UMESUE M., OMOTO K., MAEDA T. & NOMOTO K. vaccine against the intestinal nematode parasite Trichinella
Prevention of anti-T-cell receptor «6 monoclonal antibody- spiralis, 495
induced side-effects by treatment with cyclosporin A without ROBY K.F., YANG Y., GERSHON D. & HUNT JS. Cellular
interference of monoclonal antibody-induced immunosuppression distribution of proteasome subunit Lmp7 mRNA and protein in
in mice, 238 human placentas, 469
MURTAZA A. see MISRA N. ROMAN E., HARRIS D.P., JURCEVIC S., IVANYI J. &
MYERS L.K. see MIYAHARA H. MORENO C. H-2-associated effects of flanking residues on the
recognition of a permissive mycobacterial T-cell epitope, 183
NARAYAN N.P:S. see MISRA N. ROSLONIEC E.F. see MIYAHARA H.
NATH I. see MISRA N. ROSS M.J. see COE J.E.
NESBITT A.M. see MORGAN A. ROTHKOTTER H.-J. see BINNS R.M.
NICHOLSON I. see O’BRIEN R.M. ROTTEVEEL F.T.M., VAN DOORNMALEN A.M. & VAN
NICOLETTI I. see SPINOZZI F. DUIN M. sLex is not responsible for the interaction of sLex-
NIEDERKORN J.Y. see MA D. positive memory T lymphocytes with E-selectin 34
NISHIKAWA F. see KITA E. RUBIO N. see TORRES C.
NISHIMURA Y. see MURAKAMI Y.
NOMOTO K. see MURAKAMI Y. SAMSOM J.N., LANGERMANS J.A.M., SAVELKOUL H.F.J. &
see also SONODA K. VAN FURTH R. Tumour necrosis factor, but not interferon-y, is
NOTTEN W.R.F. see HOEFAKKER S. essential for acquired resistance to Listeria monocytogenes during
a secondary infection in mice, 256 :
O’BRIEN R.M., THOMAS W.R., NICHOLSON I., LAMB J.R. & SANDER B., SKANSEN-SAPHIR U., DAMM O., HAKANSSON
TAIT B.D. An immunogenetic analysis of the T-cell recognition L., ANDERSSON J. & ANDERSSON U. Sequential production
of the major house dust mite allergen Der p 2: identification of of Thl and Th2 cytokines in response to live bacillus Calmette—
high- and low-responder HLA-DQ alleles and localization of T- Guérin, 512
cell epitope, 176 SANDILANDS G.P., MCLAREN A.P., HOWIE D. &
OH-ISHI S. see KIZAKI T. MACSWEEN R.N.M. Occult expression of CD32 (FcyRI) in
OHNO H. see KIZAKI T. normal human peripheral blood mononuclear cells, 525
OKADA H. see KANEKO Y. SAVELKOUL H.F.J. see SAMSOM J.N.
OKADA N. see KANEKO Y. SCHELL R.F. see COE J.E.
OKRAGLY A.J., HANBY-FLARIDA M. & BALDWIN C.L. SCHIELEN P., VAN RODIJNEN W., PIETERS R.H.H. &
Monocytes control 76 T-cell responses by a secreted product, 599 SEINEN W. Hexachlorobenzene treatment increases the number
OMOTO K. see MURAKAMI Y. of splenic B-1-like cells and serum autoantibody levels in the rat,
OREN R., LAUFER J., GOLDBERG I., KOPOLOVIC J., 568
WALDHERR R. & PASSWELL J.H. C3, C4, factor B and SCHMITT E. see MOZZANICA N.
HLA-DRa mRNA expression in renal biopsy specimens from SCHWARZ M., MAJDIC O., KNAPP W. & HOLTER W. High-
patients with IgA nephropathy, 575 level IL-10 production by monoclonal antibody-stimulated human
OROZCO H. see HERNANDEZ-PANDO R. T cells, 364
ORSINI D.L.M., KOOY Y.M.C., VAN DER TOL M.A., STRUYK SEGUIN R., KELLER K. & CHADEE K. Entamoeba histolytica
L., VAN DEN ELSEN P. & KONING F. T-cell receptor usage stimulates the unstable transcription of c-fos and tumour necrosis
of interleukin-2-responsive peripheral y6é T cells, 385 factor-« mRNA by protein kinase C signal transduction in
OSTENSTAD B., DYBWAD A., LEA T., FORRE @., VINJE O. & macrophages, 49
SIOUD M. Evidence for monoclonal expansion of synovial T SEINEN W. see SCHIELEN P.
cells bearing Va2.1/Vf5.5 gene segments and recognizing a SEYER J.M. see MIYAHARA H.
synthetic peptide that shares homology with a number of putative SHAROM F.J. see LU P.
autoantigens, 168 SHEPHERD D. see BECKMAN I.
SHORT L. see ZUCKERMAN S.H.
PABST K.M. see MEGYERI P. SILVA C.L., PIETRO R.L.R., JANUARIO A., BONATO V.L.D.,
PABST M.J. see MEGYERI P. LIMA V.M.F., DA SILVA M.F. & LOWRIE D.B. Protection
PASSWELL J.H. see OREN R._ against tuberculosis by bone marrow cells expressing
PATARROYO M. see CASTANOS-VELEZ E. mycobacterial hsp65, 519
PATRY C., HERBELIN A., LEHUEN A., BACH J.-F. & SINGH S. see MISRA N.
MONTEIRO R.C. Fea receptors mediate release of tumour SIOUD M. see OSTENSTAD B.
necrosis factor-a and interleukin-6 by human monocytes following SJOGREN H.O. see ERIKSSON H.
receptor aggregation, | SKANSEN-SAPHIR U. see SANDER B.
PEARCE A. see BHEEKHA ESCURA R. SNIDER J. see GAVIN A.L.
PEDERSON K. see MULLER D. SONODA K., MUKASA A., MATSUZAKI G. & NOMOTO K.
PEETERS B.P.H. see KIMMAN T.G. The induction of renal autoantigen-specific T cells by a local
PENNEY L., KILSHAW P.J. & MACDONALD T.T. Regional Listeria monocytogenes infection, 190
Author Index
SOPP P. see BEMBRIDGE G_P. VIGNATI G. see MOZZANICA N.
SPIK G. see ZIMECKI M. VIKINGSSON A. see MULLER D.
SPINOZZI F., NICOLETTI I., AGEA E., BELIA S., MORACA R., VILLA M.L. see MOZZANICA N.
MIGLIORATI G., RICCARDI C., GRIGNANI F. & VINJE O. see OSTENSTAD B.
BERTOTTO A. IL-4 is able to reverse the CD2-mediated VITKUS S.J.D. see MCGEE D.W.
negative apoptotic signal to CD4- CD8* af and/or yé T VLAGOPOULOS P. see CONTI P.
lymphocytes, 379 VOERMANS J.J.M. see KIMMAN T.G.
STANKO D. see CAULFIELD M.J. VRAY B. see PLASMAN N.
STEINMAN R.M. see TALMOR M. VYAKARNAM A., MATEAR P.M., MARTIN S.J. &
STREILEIN J.W. see DAI R. WAGSTAFF M. ThI cells specific for HIV-1 gag p24 are less
STROBEL S. see FURRIE E. efficient than ThO cells in supporting HIV replication, and inhibit
STRUYK L. see ORSINI D.L.M. virus replication in Th0 cells, 85
STUART J.M. see MIYAHARA H.
SUCIU FOCA N. see HARRIS P.E. WAGNER H. see MARTINEZ-KINADER B.
SUZUKI T. see USAMI J. WAGSTAFF M. see VYAKARNAM A.
SWEET S.P., RAHMAN D. & CHALLACOMBE S.J. IgA WAKELIN D. see ROBINSON K.
subclasses in HIV disease: dichotomy between raised levels in WALDHERR R. see OREN R.
serum and decreased secretion rates in saliva, 556 WALKER B. see MISRA N.
WANG Y. see GREENWOOD J.
TAIT B.D. see O’BRIEN R.M. WASSERBAUER E. see BHEEKHA ESCURA R.
TALMOR M., STEINMAN R.M., CODNER M..A., CHEN M., WEILER J.M. see MAVES K.K.
HARPER A.D., WITMER PACK M.D. & HOFFMAN L.A. WHYTE A. see BINNS R.M.
Bone marrow-derived chimerism in non-irradiated, cyclosporin- WIEDERMANN U. see CHEN X.-J.
treated rats receiving microvascularized limb transplants: evidence WILBY M. see BINNS R.M.
for donor-derived dendritic cells in recipient lymphoid tissues, 448 WILLCOX N. see MULCAHY A..F.
TAYLOR A.M., GALLI S.J. & COLEMAN J.W. Stem-cell factor, WILLIAMS C.M.M. & COLEMAN J.W. Induced expression of
the kit ligand, induces direct degranulation of rat peritoneal mast mRNA for IL-5, IL-6, TNF-«, MIP-2 and IFN-y in
cells in vitro and in vivo: dependence of the in vitro effect on immunologically activated rat peritoneal mast cells: inhibition by
period of culture and comparisons of stem-cell factor with other dexamethasone and cyclosporin A, 244
mast cell-activating agents, 427 WILSON J.L., CUNNINGHAM A.C. & KIRBY J.A. Alloantigen
TELEMO E. see DAHLMAN-HOGLUND A. presentation by B cells: analysis of the requirement for B-cell
THEOHARIDES T.C. see CONTI P. activation, 325
THIBAULT J. see CONTI P. WITMER-PACK M.D. see TALMOR M.
THOMAS W.R. see O’BRIEN R.M.
TORRES C., ARANGUEZ I. & RUBIO N. Expression of YAMASHITA H. see KIZAKI T.
interferon-y receptors on murine oligodendrocytes and its YANG Y. see ROBY K.F.
regulation by cytokines and mitogens, 250 YAZAKI Y. see KANAMORI H.
TRABATTONI D. see MOZZANICA N. YOO D. see BACA-ESTRADA M.E.
TREVANI A:S. see ANDONEGUI G. YOSHIDA A. see KOIDE Y.
TSUCHIYA S. see MURAI M. YOSHIDA T.O. see KOIDE Y.
TURNER M.W. see FURRIE E. YOSHIKAI Y. see KITA E.
YOSHIKAI Y. see USAMI J.
UCHIJIMA M. see KOIDE Y.
UMESUE M. see MURAKAMI Y. ZENG L., AN S. & GOETZL E.J. Independent down-regulation of
USAMI J., HIROMATSU K., MATSUMOTO Y., MAEDA K.., EP, and EP; subtypes of the prostaglandin E, receptors on U937
INAGAKI H., SUZUKI T. & YOSHIKAT Y. A protective role human monocytic cells, 620
of yd T cells in primary infection with Listeria monocytogenes in ZIMECKI M., MAZURIER J., SPIK G. & KAPP J.A. Human
autoimmune non-obese diabetic mice, 199 lactoferrin induces phenotypic and functional changes in murine
splenic B cells, 122
VAJDY M. & LYCKEN. Mucosal memory B cells retain the ability ZINETTI M., GALLI G., DEMITRI M.T., FANTUZZI G.,
to produce IgM antibodies 2 years after oral immunization, 336 MINTO M., GHEZZI P., ALZANI R., COZZI E. &
VAN DEN ELSEN P. see ORSINI D.L.M. FRATELLI M. Chlorpromazine inhibits tumour necrosis factor
VAN DER TOL M.A. see ORSINI D.L.M. synthesis and cytotoxicity in vitro, 416
VAN DOORNMALEN A.M. see ROTTEVEEL F.T.M. ZOUALI M. see DEMAISON C.
VAN DUIN M. see ROTTEVEEL F.T.M. ZUCKERMAN S.H., BRYAN-POOLE N., EVANS G.F., SHORT
VAN FURTH R. see SAMSOM J.N. L. & GLASEBROOK A.L. Jn vivo modulation of murine serum
VAN JOOST TH. see HOEFAKKER S. tumour necrosis factor and interleukin-6 levels during
VAN RODIJNEN W. see SCHIELEN P. endotoxemia by oestrogen agonists and antagonists, 18

Subject Index
Acetylcholine receptor antigen: Glycosyl phosphatidylinositol anchor-deficient Raji cells, 311
presentation to T-cell line by a transfected B-cell line, 116
Adhesion molecules: Human IgG], chimeric:
expression by human alveolar epithelial cells, 279 Clq and FcyR binding sites, 319
Alloantigen presentation by B cells, 325
Anaphylatoxin CSa, human: ICAM-1:
antagonistic peptides, 149 role in chondrocyte—peripheral blood mononuclear cell
Antigen presentation: interactions, 584
in Trypanosoma cruzi-infected macrophages, 636 IgA nephropathy, C3, C4, factor Band HLA-DR« mRNA
Apoptosis, polymorphonuclear leucocyte: expression, 575
and receptor loss, 651 IgA subclasses:
in human immunodeficiency virus, 556
B-cell activation: IgE responses to Nippostongylus brasiliensis:
by hexachlorobenzene, 568 T-cell dependent and independent, 351
B-cell heterogeneity in mice, 560 IgG, novel:
B-memory cells, mucosal: hamster, 141
IgM antibody production, 336 Immune complexes:
Bacillus Calmette—Guérin infection: abrogation of B-cell unresponsiveness, 331
in anergic transgenic mice, 499 Immunomodulation:
Bone marrow chimerism: induced by cold stress, 456
in transplanted rats, 448 Interferon-y receptors, on oligodendrocytes:
Bystander suppression of immune responses, 128 regulation by cytokines and mitogens, 250
Interferons:
Cl esterase inhibitor: differential regulation of histamine and tumour necrosis factor-«
inhibition of T-cell activation, 304 in mast cells, 12
CD44 isoform: Interleukin-1 and interleukin-6 expression in human monocytes
in normal and transformed human B cells, 41 stimulated with Salmonella typhimurium porins, 612
CD45RO expression: Interleukin-2 receptor « chain:
on bovine T cells, 537 stabilization, 551
Class I-restricted presentation of exogenous proteins, 287 Interleukin-4:
Contact sensitization: reversal of CD2-mediated negative apoptotic signal, 379
on human xenografted skin, 296 Interieukin-6 secretion, by intestinal epithelial cell line:
Cyclosporin A: synergistic relationship of cytokines on, 6
prevention of anti-T-cell-receptor «f side-effects, 238 Interleukin-6:
Cytokine mRNA: production by dendritic cells, 441
up-regulation by differentiation/activation factor p48, 463 Interleukin-10:
Cytokine production in mast cells: high-level production by antibody-stimulated human T cells, 364
inhibition by dexamethasone and cyclosporin A, 244 Intraepithelial lymphocytes:
Cytokine production: variation in proliferative rates and lifespan, 212
bacillus Calmette-Guerin induced, 512
following exposure to chemical allergens, 545 Lactoferrin, human:
Cytokines: effects on murine B cells, 122
modulation of alveolar macrophage immunosuppression, 231 Langerhans’ cells, ultraviolet exposed:
production by T cells from patients with psoriasis, 422 sensitizing capacity, 661
Leucocyte tracing, pig:
Delayed-type hypersensitivity: using CD45 polymorphism, 25
characterization of moiety of ovalbumin which suppresses, 480 Lipoprotein receptors and natural killer function, 399
Lymphocyte adhesion and migration, in CNS:
Entamoeba histolytica: role of adhesion molecules, 408
stimulation of cytokine gene expression in macrophages, 49
E-selectin: %-macroglobulin:
interaction with sLex memory T cells, 34 enhancement of Fcy receptor-mediated phagocytosis, 64
Extracellular matrix proteins and integrin receptors: modification by glycosidases to a macrophage-activating factor,
in lymph nodes, 270 58
Macrophage C-type lectin:
Fca receptors: restricted expression, 591
mediation of cytokine production, | Major histocompatibility complex class I (K°) peptides:
FceRI: effects on skin graft survival and mixed lymphocyte reaction, 219
function and tissue distribution, 392 Major histocompatibility complex class I antigen presentation:
FcyRII expression, occult: by human monocytes, 606
in normal blood mononuclear cells, 525 Major histocompatibility complex class I molecules:
influence on T-cell proliferation, 71
Gangliosides: Monocyte chemotactic protein-1:
immunosuppression of interleukin-2-mediated T-cell proliferation, promotion of histamine and SHT-releasing factor for mast cells,
356 434
675
676 Subject Index
Monocyte priming: T cells, synovial fluid:
blocking by protease inhibitors, 629 monoclonal expansion of, 168
Mucosal immunity: y/6 T cells:
to bovine coronavirus, 134 T-cell receptor usage, 385
control of responses by monocytes, 599
Nitric oxide donors: in non-obese diabetic mice, 199
effects on neutrophil responses, 646 T-cell activation, CD2-induced:
in aged subjects, 533
Oestrogen: T-cell clones, T-helper type 1- and T-helper type 2-like human:
influence on CD4* T cells, 162 Toxoplasma specific, 79
T-cell epitope, mycobacterial:
Properdin, pig: H-2 effects of flanking residues on recognition, 183
cloning and characterization of cDNA, 475 T-cell epitopes:
Prostaglandin receptors: of house dust mite allergen Der p 2, 176
down-regulation, 620 T-cell responses, regulation:
Proteasome subunit Lmp7 mRNA and protein: by IgE and IgG antibodies, 343
cellular distribution, 469 T-helper cell phenotypes:
Pseudorabies virus: in leprosy, 97
immune responses in pigs, 372 T-helper cell subsets:
human immunodeficiency virus replication, 85
Salmonella typhimurium, immunity to: Tolerogenic T-cell epitope:
maintained by L forms of Salmonella typhimurium, 206 suppression of arthritis, 110
Signal transduction: Transforming growth factor-f:
by B7/BB1 on activated T cells, 155 down-regulation of major histocompatibility complex class I and
Stem-cell factor: increased susceptibility to natural killer cytokines, 263
activation of mast cells, 427 Tuberculosis:
Superantigen: protection against by bone marrow cells expressing mycobacterial
enhancement of immunoglobulin production in SCID mice hsp65, 519
following priming of B cells, 224 Tumour necrosis factor and interleukin-6:
Synthetic peptide vaccine: modulation of oestrogen agonists and antagonists, 18
against Trichinella spiralis, 495 Tumour necrosis factor synthesis:
inhibition by chlorpromazine, 416
T cells, autoreactive: Tumour necrosis factor:
induced by Listeria monocytogenes infection, 190 role in acquired resistance to Listeria monocytogenes, 256
T cells, phenotypical characterization:
in patients with coeliac disease, 104 V-region genes, of anti-Sm and anti-cardiolipin autoantibodies, 487